CNXCConcentrix Corp

Nasdaq concentrix.com


$ 57.29 $ 1.98 (3.58 %)    

Thursday, 02-May-2024 15:59:53 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 57.28
$ 55.68
$ 0.00 x 0
$ 0.00 x 0
$ 55.09 - $ 58.28
$ 53.87 - $ 105.18
498,632
na
3.77B
$ 0.89
$ 13.55
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-05-2024 02-29-2024 10-Q
2 01-29-2024 11-30-2023 10-K
3 10-06-2023 08-31-2023 10-Q
4 07-07-2023 05-31-2023 10-Q
5 04-07-2023 02-28-2023 10-Q
6 01-27-2023 11-30-2022 10-K
7 10-07-2022 08-31-2022 10-Q
8 07-08-2022 05-31-2022 10-Q
9 04-08-2022 02-28-2022 10-Q
10 01-28-2022 11-30-2021 10-K
11 10-08-2021 08-31-2021 10-Q
12 07-09-2021 05-31-2021 10-Q
13 04-09-2021 02-28-2021 10-Q
14 02-16-2021 11-30-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 scotiabank-maintains-sector-outperform-on-concentrix-lowers-price-target-to-85

Scotiabank analyst Divya Goyal maintains Concentrix (NASDAQ:CNXC) with a Sector Outperform and lowers the price target from ...

 on-april-25-concentrix-corp-entered-into-an-amendment-to-its-accounts-receivable-securitization-facility-amendment-provides-for-increase-in-commitment-of-lenders-to-provide-available-borrowings-from-up-to-500m-to-up-to-600m-amendment-provides-for-an-extension-of-termination-date-of-securitization-facility-from-july-5-2024-to-april-24-2026

- SEC Filing

 concentrix--webhelp-rebrands-as-concentrix

Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader that has been operating under the trade name of C...

 wondering-where-to-find-an-over-7-annual-return-check-out-these-10-investment-grade-corporate-bonds

Corporate bonds offer yield opportunities and diversification away from equity investments. Investment-grade bonds are safer bu...

 b-of-a-securities-downgrades-concentrix-to-underperform

B of A Securities analyst Ruplu Bhattacharya downgrades Concentrix (NASDAQ:CNXC) from Neutral to Underperform.

 barrington-research-maintains-outperform-on-concentrix-lowers-price-target-to-84

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and lowers the price targ...

 concentrix-committed-to-share-repurchases-of-100m-over-remainder-of-2024

Quarterly Dividend and Share Repurchase Program:The Company paid a $0.3025 per share quarterly dividend on February 15, 2024. T...

 concentrix-sees-q2-eps-255-270-vs-283-est-revenue-2325b-2372b-vs-237b-est-fy24-eps-1169-1250-vs-1196-est-revenue-951b-970b-vs-963b-est

Second Quarter Fiscal 2024 Expectations:Second quarter reported revenue is expected to be in the range of $2.325 billion to $2....

 concentrix-q1-eps-257-misses-258-estimate-sales-240b-beat-238b-estimate

Concentrix (NASDAQ:CNXC) reported quarterly earnings of $2.57 per share which missed the analyst consensus estimate of $2.58 by...

 earnings-scheduled-for-march-26-2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

 concentrix-earnings-preview
Concentrix Earnings Preview
03/25/2024 14:00:53

 barrington-research-maintains-outperform-on-concentrix-maintains-121-price-target

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and maintains $121 price ...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 why-humana-shares-are-trading-lower-by-over-11-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earning...

 barrington-research-maintains-outperform-on-concentrix-raises-price-target-to-121

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and raises the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION